6-K

Commission File Number 001-31914

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13A-16 or 15d-16

of the Securities Exchange Act of 1934

July 18, 2022

China Life Insurance Company Limited

(Translation of registrant’s name into English)

16 Financial Street

Xicheng District

Beijing 100033, China

Tel: (86-10) 6363-3333

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes  ☐            No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-                        

Commission File Number 001-31914

China Life Insurance Company Limited issued an announcement on July 18, 2022, a copy of which is attached as Exhibit 99.1 hereto.

EXHIBIT LIST

Exhibit	Description
99.1	Announcement,dated July 18, 2022

Commission File Number 001-31914

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

China Life Insurance Company Limited
	(Registrant)

	By:	/s/ Su Hengxuan
		(Signature)
July 18, 2022	Name:	Su Hengxuan
	Title:	President and Executive Director

EX-99.1

Commission File Number 001-31914

EXHIBIT 99.1

ANNOUNCEMENT

APPROVAL OF QUALIFICATION AS SUPERVISOR BY THE CBIRC AND RESIGNATION OF SUPERVISOR

Reference is made to the announcement of China Life Insurance Company Limited (the “Company”) dated 1 April 2022 in relation to the election of Ms. Hu Zhijun as an Employee Representative Supervisor of the seventh session of the board of supervisors of the Company (the “Board of Supervisors”) at the eighth extraordinary meeting of the third session of the employee representative meeting of the Company.

The Company has recently received the approval of qualification of Ms. Hu Zhijun issued by the China Banking and Insurance Regulatory Commission (the “CBIRC”). Pursuant to the approval, the qualification of Ms. Hu Zhijun as a Supervisor of the Company has been approved by the CBIRC. The term of office of Ms. Hu Zhijun commenced on 13 July 2022. For the biographical details of Ms. Hu Zhijun, please refer to the announcement of the Company dated 1 April 2022.

In addition, due to adjustment of work arrangements, Mr. Cao Qingyang has tendered his resignation as an Employee Representative Supervisor of the Company on 18 July 2022, which took effect on the same day.

Mr. Cao Qingyang has confirmed that he has no disagreement with the Board of Supervisors and there are no other matters relating to his resignation that need to be brought to the attention of the shareholders of the Company. The Company would like to express its gratitude to Mr. Cao Qingyang for his contribution to the Company during his tenure of service.

By Order of the Board

China Life Insurance Company Limited

Heng Victor Ja Wei

Company Secretary

Commission File Number 001-31914

Hong Kong, 18 July 2022

As at the date of this announcement, the Board of the Company comprises:

Executive Directors:	Bai Tao, Su Hengxuan, Li Mingguang, Huang Xiumei
Non-executive Director:	Wang Junhui
Independent Non-executive Directors:	Lam Chi Kuen, Zhai Haitao, Huang Yiping, Chen Jie